National Institute of Allergy and Infectious Diseases; Notice of Meeting, 21259 [2024-06461]
Download as PDF
Federal Register / Vol. 89, No. 60 / Wednesday, March 27, 2024 / Notices
subset of 50 recordkeepers who
maintain written procedures and
records specifically required by
§ 589.2001(c).
Based on our review since the last
OMB approval, there is an overall
adjustment decrease of 2,565 burden
hours. The adjustment is attributable to
decreases in the average reporting
burden time and in respondents subject
to recordkeeping requirements.
Dated: March 21, 2024.
Lauren K. Roth,
Associate Commissioner for Policy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Meeting
khammond on DSKJM1Z7X2PROD with NOTICES
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the AIDS Research Advisory
Committee, NIAID.
This will be a hybrid meeting held inperson and virtually and will be open to
the public as indicated below.
Individuals who plan to attend inperson or view the virtual meeting and
need special assistance or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting. The meeting
can be accessed from the NIH Videocast
at the following link: https://videocast.
nih.gov/.
Name of Committee: AIDS Research
Advisory Committee, NIAID.
Date: June 3, 2024.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: Report of Division Director and
Division Staff.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Grand Hall,
Rockville, MD 20852 (Hybrid Meeting).
Contact Person: Pamela Gilden, Branch
Chief, Science Planning and Operations
Branch, Division of AIDS, National Institute
of Allergy and Infectious Diseases, National
Institutes of Health, 5601 Fishers Lane, MSC
9831, Rockville, MD 20852–9831, 301–594–
9954, pamela.gilden@nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Jkt 262001
[FR Doc. 2024–06461 Filed 3–26–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institute of Allergy and
Infectious Diseases; Notice of
Meetings
BILLING CODE 4164–01–P
17:03 Mar 26, 2024
Dated: March 21, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory
Committee Policy.
National Institutes of Health
[FR Doc. 2024–06438 Filed 3–26–24; 8:45 am]
VerDate Sep<11>2014
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of
meetings of the National Advisory
Allergy and Infectious Diseases Council.
A portion of the meetings will be
open to the public as indicated below,
with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Allergy and Infectious Diseases Council.
Date: June 3, 2024.
Open: 10:30 a.m. to 11:30 a.m.
Agenda: Report of Institute Director.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Grand Hall,
Rockville, MD 20852 (Hybrid Meeting).
Closed: 11:45 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Grand Hall,
Rockville, MD 20852 (Hybrid Meeting).
Contact Person: Kelly Y. Poe, Ph.D.,
Director, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601
Fishers Lane, Room 3F40B, Bethesda, MD
20892–9834, (240) 669–5036, poeky@
mail.nih.gov.
Name of Committee: National Advisory
Allergy and Infectious Diseases Council;
PO 00000
Frm 00027
Fmt 4703
Sfmt 4703
21259
Microbiology and Infectious Diseases
Subcommittee.
Date: June 3, 2024.
Closed: 8:30 a.m. to 10:15 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Garden Room 2,
Rockville, MD 20852 (Hybrid Meeting).
Open: 1:00 p.m. to 4:00 p.m.
Agenda: Report of the Division Director
and Division Staff.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Garden Room 2,
Rockville, MD 20852 (Hybrid Meeting).
Contact Person: Kelly Y. Poe, Ph.D.,
Director, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601
Fishers Lane, Room 3F40B Bethesda, MD
20892–9834, (240) 669–5036, poeky@
mail.nih.gov.
Name of Committee: National Advisory
Allergy and Infectious Diseases Council;
Immunology and Transplantation
Subcommittee.
Date: June 3, 2024.
Closed: 8:30 a.m. to 10:15 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Garden Room 1,
Rockville, MD 20852 (Hybrid Meeting).
Open: 1:00 p.m. to 4:00 p.m.
Agenda: Report of the Division Director
and Division Staff.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Garden Room 1,
Rockville, MD 20852 (Hybrid Meeting).
Contact Person: Kelly Y. Poe, Ph.D.,
Director, Division of Extramural Activities,
National Institutes of Health, NIAID, National
Institutes of Health, 5601 Fishers Lane, Room
3F40B, Bethesda, MD 20892–9834, (240)
669–5036, poeky@mail.nih.gov.
Name of Committee: National Advisory
Allergy and Infectious Diseases Council;
Acquired Immunodeficiency Syndrome
Subcommittee.
Date: June 3, 2024.
Closed: 8:30 a.m. to 10:15 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Grand Hall,
Rockville, MD 20852 (Hybrid Meeting).
Open: 1:00 p.m. to 4:00 p.m.
Agenda: Report of the Division Director
and Division Staff.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, Conference Room: Grand Hall, 5601
Fishers Lane, Rockville, MD 20852 (Hybrid
Meeting).
Contact Person: Kelly Y. Poe, Ph.D.,
Director, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601
Fishers Lane, Room 3F40B, Bethesda, MD
20892–9834, (240) 669–5036, poeky@
mail.nih.gov.
E:\FR\FM\27MRN1.SGM
27MRN1
Agencies
[Federal Register Volume 89, Number 60 (Wednesday, March 27, 2024)]
[Notices]
[Page 21259]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-06461]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the AIDS Research
Advisory Committee, NIAID.
This will be a hybrid meeting held in-person and virtually and will
be open to the public as indicated below. Individuals who plan to
attend in-person or view the virtual meeting and need special
assistance or other reasonable accommodations, should notify the
Contact Person listed below in advance of the meeting. The meeting can
be accessed from the NIH Videocast at the following link: https://videocast.nih.gov/.
Name of Committee: AIDS Research Advisory Committee, NIAID.
Date: June 3, 2024.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: Report of Division Director and Division Staff.
Place: National Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers Lane, Grand Hall,
Rockville, MD 20852 (Hybrid Meeting).
Contact Person: Pamela Gilden, Branch Chief, Science Planning
and Operations Branch, Division of AIDS, National Institute of
Allergy and Infectious Diseases, National Institutes of Health, 5601
Fishers Lane, MSC 9831, Rockville, MD 20852-9831, 301-594-9954,
[email protected].
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: March 21, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-06461 Filed 3-26-24; 8:45 am]
BILLING CODE 4140-01-P